Evidence map›Paper›PMID 22879945›Full record

Trial reportPloS one2012

Quantitative normative gait data in a large cohort of ambulatory persons with Parkinson's disease.

Chris J Hass, Paul Malczak, Joe Nocera, Elizabeth L Stegemöller, Aparna Wagle Shukla, Aparna Shukala, Irene Malaty, Charles E Jacobson, Michael S Okun, Nick McFarland

Erratum issuedAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 51 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. A meta-analysis: Parkinson's disease and dual-task walking.Parkinsonism & related disorders · 2019
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

  • Erratum issued
    Shukala, Aparna [corrected to Wagle Shukla, Aparna]
5 · Who and what money

Authors and funding

10 authors.

Chris J HassCenter for Movement Disorders and Neurorestoration, University of Florida, Gainesville, Florida, United States of America. cjhass@hhp.ufl.edu
Paul Malczak
Joe Nocera
Elizabeth L Stegemöller
Aparna Wagle Shukla
Aparna Shukala
Irene Malaty
Charles E Jacobson
Michael S Okun
Nick McFarland

Funding

UF Clinical and Translational Science AwardUL1TR000064 · NCATS · UNIVERSITY OF FLORIDA · PI NELSON, DAVID R · 2012 to 2014
$12.2M
Rab proteins and alpha-Synuclein toxicity in Neurodegenerative DiseaseK08NS067024 · NINDS · UNIVERSITY OF FLORIDA · PI MCFARLAND, NIKOLAUS RENZ · 2010 to 2014
$904k
Language and Executive Function in Parkinson's Disease: Effects of dual task andR21AG033284 · NIA · UNIVERSITY OF FLORIDA · PI ALTMANN, LORI J., HASS, CHRISTOPHER J. · 2010 to 2011
$330k
NCATS NIH HHS UL1 TR000064NIA NIH HHS NIH R21AG033284-1R2NIA NIH HHS R21 AG033284NINDS NIH HHS K08 NS067024
6 · The paper itself

Abstract

backgroundGait performance is widely evaluated to assess health status in older adult populations. While several investigators have presented normative values for spatiotemporal gait parameters drawn from older adult populations, the literature has been void of large-scale cohort studies, which are needed in order to provide quantitative, normative gait data in persons with Parkinson's disease. The aim of this investigation was to provide reference values for clinically important gait characteristics in a large sample of ambulatory persons with Parkinson's disease to aid both clinicians and researchers in their evaluations and treatments of gait impairment. METHODOLOGY/PRINCIPAL

findingsGait performance was collected in 310 individuals with idiopathic Parkinson's disease as they walked across a pressure sensitive walkway. Fourteen quantitative gait parameters were measured and evaluated with respect to Hoehn and Yahr disease staging and gender. Disease duration and age were controlled for in all analyses. Individuals with the greatest Parkinson's disability walked significantly slower with shorter steps and stride lengths than the mild and moderately affected groups. Further, the most affected patients spent more time with both feet on the ground, and walked with a wider base of support than the moderately disabled patients. No differences were detected between the mild and moderate disability groups on any of the gait parameters evaluated. CONCLUSIONS/SIGNIFICANCE: Reference values for 14 gait parameters in a large cohort of ambulatory patients with Parkinson's disease are provided and these may be highly useful for assessing and interpreting an individual's gait dysfunction. It is important for clinicians and researchers to appreciate the lack of change in quantitative parameters as PD patients move from mild to moderate gait impairment.

Indexed as

AdultAgedCohort StudiesDemographyFemaleGaitHumansMaleParkinson DiseaseTime FactorsWalking

Identifiers

PMID22879945
PMCPMC3411737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.